American Family Physician, 96 (6), 384389
Johnson, W., Bergfeld, W
However, the disparity between mechanistic promise and clinical maturity has direct implications for patient counselling, trial design, regulatory oversight, and ethical considerations surrounding the off-label and grey-market use of these therapies
From the gut to the joints, and from tendons to muscles, BPC-157 continues to gain attention among wellness practitioners, sports recovery experts, and individuals seeking advanced support for total body repair
What the evidence covers today (and what's still missing) The weight-loss conversation would be easier if we had large, controlled human trials measuring fat-loss outcomes
For patients reading this: its understandable to be enticed by the promise of a quick fix for chronic pain or a faster injury recovery